IDEATE IPILIMUMAB DRUG EVALUATION IMMUNOTHERAPY IN SQUAMOUS NSCLC - Trademark Details
Status: 710 - Cancelled - Section 8
Image for trademark with serial number 85595704
Serial Number
85595704
Registration Number
4485747
Word Mark
IDEATE IPILIMUMAB DRUG EVALUATION IMMUNOTHERAPY IN SQUAMOUS NSCLC
Status
710 - Cancelled - Section 8
Status Date
2020-09-25
Filing Date
2012-04-12
Registration Number
4485747
Registration Date
2014-02-18
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
032315, 260129, 261121, 261125, 261126 - Micro-organisms (including sperms). Helixes. Rectangles that are completely or partially shaded. Rectangles with one or more curved sides. Oblongs as carriers for words, letters or designs.
Published for Opposition Date
2013-03-19
Attorney Name
Marilyn F. Kelly
Law Office Assigned Location Code
M30
Employee Name
HELLMAN, ELI J
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"IPILIMUMAB DRUG EVALUATION" AND "IMMUNOTHERAPY IN SQUAMOUS NSCLC"
Description of Mark
The mark consists of the words "IDEATE IPILIMUMAB DRUG EVALUATION" in stylized letters above an oblong containing the words "IMMUNOTHERAPY IN SQUAMOUS NSCLC", all against stylized chromosomes and a stylized DNA strand.
Goods and Services
Product research and development; conducting clinical trials relating to pharmaceutical preparations for human use
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2020-09-25
Primary Code
042
First Use Anywhere Date
2013-05-31
First Use In Commerce Date
2013-05-31
Correspondences
Name
Marilyn F. Kelly
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Prior Registration3677086
Trademark Events
Event DateEvent Description
2012-04-17NEW APPLICATION ENTERED IN TRAM
2012-04-19NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2012-04-20NOTICE OF DESIGN SEARCH CODE MAILED
2012-06-29ASSIGNED TO EXAMINER
2012-07-06NON-FINAL ACTION WRITTEN
2012-07-06NON-FINAL ACTION E-MAILED
2012-07-06NOTIFICATION OF NON-FINAL ACTION E-MAILED
2013-01-02TEAS RESPONSE TO OFFICE ACTION RECEIVED
2013-01-02CORRESPONDENCE RECEIVED IN LAW OFFICE
2013-01-02TEAS/EMAIL CORRESPONDENCE ENTERED
2013-01-27APPROVED FOR PUB - PRINCIPAL REGISTER
2013-02-07ASSIGNED TO LIE
2013-02-08LAW OFFICE PUBLICATION REVIEW COMPLETED
2013-02-27NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2013-03-12TEAS CHANGE OF CORRESPONDENCE RECEIVED
2013-03-19PUBLISHED FOR OPPOSITION
2013-03-19OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2013-05-14NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2013-07-03ASSIGNED TO EXAMINER
2013-11-07TEAS STATEMENT OF USE RECEIVED
2013-11-07TEAS EXTENSION RECEIVED
2013-12-10CASE ASSIGNED TO INTENT TO USE PARALEGAL
2013-12-31CASE ASSIGNED TO INTENT TO USE PARALEGAL
2013-11-07EXTENSION 1 FILED
2014-01-09EXTENSION 1 GRANTED
2013-11-07USE AMENDMENT FILED
2014-01-09STATEMENT OF USE PROCESSING COMPLETE
2014-01-09ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2014-01-10NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2014-01-10LAW OFFICE REGISTRATION REVIEW COMPLETED
2014-01-11NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2014-02-18REGISTERED-PRINCIPAL REGISTER
2018-08-21TEAS CHANGE OF OWNER ADDRESS RECEIVED
2018-08-21APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2018-10-08TEAS CHANGE OF OWNER ADDRESS RECEIVED
2018-10-08APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2019-02-18COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
2020-09-25CANCELLED SEC. 8 (6-YR)